n.zielinski

TL2 · Nairobi

Contributes reviews on supplier material. Based in Nairobi.

Joined 21 May 2025 · last posted 18h

81 posts, newest first. Showing up to 150.

Stability of BPC-157 in solution: what has been measured — one year on Replied, post #99 · Compounds › Repair & healing peptides · 27 Jul 2026 · 11 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series.
Coming back to: A structured critique template this community uses Replied, post #69 · Evidence › Study critique · 26 Jul 2026 · 4 likes Whatever the answer on structured critique template turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite…
Transit times by route, from a logged dataset Replied, post #29 · Sourcing › Logistics · 23 Jul 2026 · 7 likes An update on my earlier transit times post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
What a certificate commits its issuer to Replied, post #80 · Analytics › COA interpretation · 22 Jul 2026 · 21 likes On post #76 — agreed on the reasoning, with one qualification. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #18 · Clinical › Prescriber conversations · 19 Jul 2026 · 1 like Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
Here for the analytics and not much else Replied, post #52 · Lounge › Introductions · 18 Jul 2026 · 23 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
What a reversed-phase purity number actually is Replied, post #65 · Analytics › HPLC & UHPLC · 17 Jul 2026 · 6 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #4 · Compounds › Oral incretins · 17 Jul 2026 · 22 likes Trial adherence in an oral trial with strict administration requirements is genuinely worse than trial-published data often suggests. That is why the exposure…
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #79 · Analytics › Home & field testing · 17 Jul 2026 · 3 likes I read post #77 twice before replying, because I had assumed the opposite. Reading a colorimetric result at the wrong time is the commonest procedural error.…
Priming a pen and whether the primed volume is wasted Replied, post #9 · Devices › Pens & autoinjectors · 17 Jul 2026 · 31 likes On post #5 — agreed on the reasoning, with one qualification. Disposal of a used pen is a sharps question even where the needle is retracted, and local rules vary more…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #125 · Practice › Reconstitution · 15 Jul 2026 · 18 likes Reading rather than contributing, but this is the most useful thread I have found on it.
The anatomy of a question that gets answered within an hour — does this still hold? Replied, post #19 · Start Here › How to Ask · 13 Jul 2026 · 20 likes Coming back to post #16, because the follow-up matters more than the original answer. Quantities without units are the single commonest reason a question sits…
CJC-1295 with and without DAC: what the modification does Replied, post #100 · Compounds › Secretagogues & GH axis · 2 Jul 2026 · 0 likes If someone has run CJC-1295 properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
Talking to a therapist about this specifically Replied, post #15 · Wellbeing › Mental health · 23 Jun 2026 · 10 likes Coming back to post #14, because the follow-up matters more than the original answer. Where a member is finding this hard, the useful reply is usually a question rather…
A pooled estimate that changed when one trial was added Replied, post #8 · Evidence › Meta-analyses · 10 Jun 2026 · 8 likes That is clearer than the version I had in my head. Thank you.
A site rotation scheme that is easy enough to actually follow Replied, post #74 · Practice › Administration · 28 May 2026 · 3 likes Post #73 answers the question as asked. The question underneath it is different. Distinguishing three things in the site rotation scheme discussion that keep getting…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #120 · Practice › Storage & stability · 22 May 2026 · 0 likes Bookmarking this. I will come back when I have something worth adding.
Revisiting: Patterns that reliably precede a problem, documented Replied, post #2 · Sourcing › Red flags · 18 May 2026 · 0 likes Screenshots without provenance are the weakest form of evidence circulating here, and they travel further than anything better documented. It cost nothing to check and…
Revisiting: A field-by-field walk through a certificate of analysis Replied, post #26 · Analytics › COA interpretation · 2 May 2026 · 18 likes Post #25 is right about the mechanism and I think understates the practical bit. A chromatogram supplied as a small image is legible for peak shape and not for baseline…
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #13 · Pharmacology › Pharmacokinetics · 11 Apr 2026 · 1 like Good question, well framed, and I would like to see it answered properly.
Spike-and-recover accuracy for a peptide assay Replied, post #67 · Analytics › Method validation · 9 Apr 2026 · 5 likes Post #65 answers the question as asked. The question underneath it is different. The claim about spike-and-recover accuracy upthread is stronger than its source…
Sample handling between despatch and injection Replied, post #11 · Analytics › Method validation · 1 Apr 2026 · 10 likes Post #10 is right about the mechanism and I think understates the practical bit. Sample handling between despatch is well covered in the tag pages, and the older…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #85 · Pharmacology › Pharmacokinetics · 27 Mar 2026 · 15 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #35 · Sourcing › Vendor reports · 14 Mar 2026 · 6 likes The maintainers will ask for missing fields rather than rejecting a report. Filling them in afterwards is normal and nobody minds.
[2026 update] Composite endpoints and the component doing the work Replied, post #21 · Evidence › Trials · 6 Mar 2026 · 13 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
The lowest dose that does anything: is that a real question? Replied, post #56 · Practice › Dosing & titration · 5 Mar 2026 · 19 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
Rotating between abdomen, thigh and upper arm: absorption differences Replied, post #2 · Practice › Administration · 19 Feb 2026 · 3 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Heterogeneity as information rather than as a nuisance Replied, post #92 · Evidence › Meta-analyses · 6 Feb 2026 · 9 likes This follows post #89 rather than contradicting it. Careful with the language on heterogeneity. "Not detected" and "not present" are different findings and the first is…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #82 · Access › International · 30 Jan 2026 · 12 likes Language barriers: if you need to communicate with a supplier, clinician, or regulator in a language not your first language, misunderstanding is possible. Clarify when…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #13 · Clinical › Special populations · 21 Jan 2026 · 3 likes Picking up post #10: that is the part I would want checked first. Post-surgical populations, particularly after procedures affecting the gastrointestinal tract,…
Muscle cramps: the ordinary causes before the exotic ones Replied, post #80 · Practice › Side effects · 20 Jan 2026 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
Muscle cramps: the ordinary causes before the exotic ones Replied, post #7 · Practice › Side effects · 12 Jan 2026 · 13 likes The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates from a forum are not comparable and are biased by…
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #46 · Regional › UK & Ireland · 7 Jan 2026 · 27 likes Source for the Private prescribing figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
Reverse causation in a cohort study of weight and outcome Replied, post #7 · Evidence › Study critique · 29 Dec 2025 · 0 likes Post #6 answers the question as asked. The question underneath it is different. Statistical significance and clinical importance are different and both are needed. A…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #14 · Compounds › Oral incretins · 19 Dec 2025 · 21 likes This follows post #12 rather than contradicting it. Tablet integrity matters more than people expect for a formulation that depends on an absorption enhancer released…
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #75 · Compounds › Oral incretins · 18 Dec 2025 · 7 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
Gastro-oesophageal reflux: improving or worsening? Replied, post #3 · Clinical › Comorbidities · 5 Dec 2025 · 13 likes Same experience here, different supplier, so it is at least not unique to one of them.
Non-inferiority margins: how they are chosen and how they are abused Replied, post #20 · Evidence › Trials · 1 Dec 2025 · 2 likes Adding a note of thanks rather than an opinion. I did not know most of that.
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #9 · Compounds › Tirzepatide · 1 Dec 2025 · 29 likes Post #8 answers the question as asked. The question underneath it is different. The reason 2.5 mg starting dose keeps being re-asked is that the answer is conditional…
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #37 · Compounds › Oral incretins · 9 Nov 2025 · 1 like Post #36 is right about the mechanism and I think understates the practical bit. Orforglipron is a small molecule rather than a peptide, which changes almost everything…
Reconciling a supplier certificate with an independent result Replied, post #21 · Sourcing › Vendor reports · 3 Nov 2025 · 27 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #128 · Compounds › Tirzepatide · 24 Oct 2025 · 0 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
Sleep tracking data and its considerable limitations Replied, post #69 · Wellbeing › Sleep · 23 Oct 2025 · 3 likes That matches what I have seen, for whatever a single anecdote is worth.
Research-use-only labelling: what it means and what it does not Replied, post #48 · Sourcing › Regulatory · 20 Oct 2025 · 30 likes Coming back to post #46, because the follow-up matters more than the original answer. What I can speak to on research-use-only labelling is narrow, so I will keep it…
Follow-up: Why appetite effects are mostly central Replied, post #66 · Pharmacology › Receptor biology · 13 Oct 2025 · 10 likes Thank you — that answers what I came here to find out.
Aggregated purity results across four services, with caveats — a second dataset Replied, post #152 · Data & Tools › Datasets · 11 Sep 2025 · 12 likes Post #151 answers the question as asked. The question underneath it is different. Practical answer on Aggregated purity results across four, since the theoretical one…
Managing an unplanned gap in supply — what changed since Replied, post #56 · Access › Shortages · 7 Sep 2025 · 19 likes Post #54 answers the question as asked. The question underneath it is different. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are…
When a preprint is the best available evidence and we say so Replied, post #133 · Evidence › Preprints · 3 Sep 2025 · 2 likes The arithmetic on preprint is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #103 · Compounds › Secretagogues & GH axis · 27 Aug 2025 · 0 likes Bookmarking this. I will come back when I have something worth adding.
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #39 · Compounds › Semaglutide · 9 Aug 2025 · 1 like Semaglutide versus liraglutide in STEP 8: semaglutide produced greater weight reduction and the discontinuation rates differed. But the trial was open-label for the…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #7 · Evidence › Journal club · 8 Aug 2025 · 1 like This follows post #4 rather than contradicting it. Two things can be true about orforglipron phase 2 at once: the mechanism is plausible and the evidence for the size…
A ten-fold dose error caught before injection — one year on Replied, post #119 · Devices › Syringes & needles · 4 Aug 2025 · 12 likes Post #118 answers the question as asked. The question underneath it is different. Graduation spacing is worth checking before you buy rather than after. Some 1 mL…
The C-cell question: rodent findings and their human context Replied, post #44 · Compounds › Semaglutide · 28 Jul 2025 · 30 likes Two questions I would want answered before drawing anything from the c-cell question data above: how were the cases selected, and what happened to the ones that dropped…
Thyroid function tests during substantial weight change Replied, post #13 · Clinical › Bloodwork · 25 Jul 2025 · 1 like Worth separating two things that post #9 runs together. Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard…
Substitution between formats during a shortage Replied, post #25 · Access › Shortages · 19 Jul 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
Regression to the mean in progress reports Replied, post #30 · Research Methods › Statistics · 8 Jul 2025 · 27 likes On regression, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Thyroid function tests during substantial weight change Started this topic · Clinical › Bloodwork · 4 Jul 2025 · 0 likes Posting this under the heading it deserves: Thyroid function tests during substantial weight change Everything below is what sits behind that. I was wrong about thyroid…
Subcutaneous absorption kinetics and site differences Replied, post #12 · Pharmacology › Pharmacokinetics · 1 Jul 2025 · 1 like The practical upshot of week-long kinetics is that nothing you do this week is fully visible until next month. Most impatience in this field is a kinetics…
Repeatability versus intermediate precision Replied, post #93 · Analytics › Method validation · 29 Jun 2025 · 20 likes Speaking only to repeatability versus intermediate precision as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #53 · Evidence › Trials · 15 Jun 2025 · 7 likes Thank you for taking the time. That was more work than a reply usually is.
Validating a calculator against hand arithmetic — what changed since Replied, post #130 · Data & Tools › Calculators · 12 Jun 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
What a documentation review can and cannot tell you Replied, post #3 · marked as the solution · Sourcing › Independent verification · 10 Jun 2025 · 7 likes Verified here means specific lots were independently measured on stated dates by named services and the results were consistent with the documentation. It is narrower…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #11 · Sourcing › Regulatory · 1 Jun 2025 · 4 likes This is the sort of exchange that makes the archive worth searching.
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #47 · Sourcing › Independent verification · 26 May 2025 · 8 likes I read post #46 twice before replying, because I had assumed the opposite. I would rather this thread reach "we do not know" about splitting a vial than reach a…
Storing a pen in use versus a pen unopened Replied, post #15 · Devices › Pens & autoinjectors · 21 May 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #42 · Evidence › Journal club · 20 May 2025 · 0 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.
Coverage for the indication versus for the drug Replied, post #57 · Access › Insurance & coverage · 8 May 2025 · 13 likes Post #56 is right about the mechanism and I think understates the practical bit. Formulary status: the list of covered medications and the tier (how much you pay) they…
Carryover and the ghost peak from last week's standard Replied, post #32 · Analytics › HPLC & UHPLC · 5 Apr 2025 · 14 likes Column temperature affects retention and selectivity and is omitted from most certificates. Two runs at twenty-five and forty degrees are not the same method.
Coming back to: An 18-month record including the parts that went badly Replied, post #34 · Outcomes › Progress reports · 1 Apr 2025 · 2 likes I disagree with the framing of 18-month record above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be…
Counter-ion content and its effect on measured mass Replied, post #9 · Analytics › Mass spectrometry · 1 Apr 2025 · 13 likes Bookmarking this. I will come back when I have something worth adding.
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #36 · Evidence › Meta-analyses · 1 Feb 2025 · 24 likes The useful distinction on Random versus fixed effects is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them…
When "no data" is the complete and final answer Replied, post #75 · Compounds › Other compounds · 25 Jan 2025 · 24 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #54 · Analytics › COA interpretation · 25 Jan 2025 · 3 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #49 · Compounds › Semaglutide · 21 Dec 2024 · 12 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #131 · Compounds › Repair & healing peptides · 24 Nov 2024 · 22 likes This follows post #130 rather than contradicting it. Filing a mild objection to the consensus on reading a preclinical wound-healing model. Mild because I might be…
Requesting a page: what makes a good request — what changed since Replied, post #47 · Documentation › Wiki requests · 10 Oct 2024 · 5 likes Picking up post #44: that is the part I would want checked first. Format suggestions: if you think a maintained page could be clearer in its presentation (different…
The C-cell question: rodent findings and their human context — what changed since Replied, post #41 · Compounds › Semaglutide · 8 Sep 2024 · 26 likes Worth separating two things that post #37 runs together. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach…
The mass-error checker and its intended scope Replied, post #120 · Data & Tools › Calculators · 13 Jul 2024 · 0 likes This follows post #118 rather than contradicting it. A calculator that shows its working is worth ten that give an answer. The whole value is being able to see which…
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #106 · Practice › Dosing & titration · 9 Jul 2024 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
The mass-error checker and its intended scope Replied, post #97 · Data & Tools › Calculators · 4 Jul 2024 · 22 likes Adding a null result on mass-error checker. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
How this community labels and discusses unrefereed work Replied, post #40 · Evidence › Preprints · 25 Jun 2024 · 0 likes Discussing preprints in this community: bring them in for early discussion, label them clearly as preprints, invite peer critique, and be prepared for the discussion to…